References
- Cubeddu LX, Hoffmann IS, Fuemnayor NT, et al. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cispiatin-induced nausea and vomiting. N Engl J Med 1990; 322(12): 810–6
- Meyer BR, O'Mara V, Reidenberg MM. A controlled clinical trial of the addition of transdermal scopolamine to a standard meto-clopramide and dexamethasone antiemetic regimen. J Clin Oncol 1987; 5(12): 1994–7
- Gralla RJ, ltri LM, Pisko SE, et al. Antiemetic efficacy of high-dose metoclopra-mide: randomized trials with placebo and pro-chlorperazine in patients with chemotherapy- induced nausea and vomiting. N Engl J Med 1981; 305(16): 905–9
- Carr BI, Blayney DW, Goldberg DA, et al. High doses of prochlorperazine for cisplatin-induced emesis: a prospective, random, dose-response study. Cancer 1987;60(9): 2165–9
- Granberg SM, Gala KV, Lampenfeld M, et al. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. J Clin Oncol 1984; 2(7): 782–7
- Lee BJ. Methylprednisolone as an antiemetic. (Letter) N EnglJ Med 1981; 304(8): 486
- Cassileth PA, Lusk EJ, Torri S, et al. Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 1983; 143(7): 1347–9
- Laszlo J, Clark RA, Hanson DC, et al. Lorazepam in cancer patients treated with cisplatin: a drug having antiemedc, amnesic, and anxiolytic effects. J Clin Oncol 1985; 3(6): 864–9
- Meyer BR, Lewin M, Drayer DE, et al. Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med 1984;100(3): 393–5
- Anthony LB, Krozely MG, Woodward NJ, et al. Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial. J Clin Oncol 1986; 4(1): 98–103
- Kris MG, Tyson LB, Gralla RJ, et al. Extrapyramidal reactions with high-dose metoclopramide. (Letter) N Engl J Med 1983:309(7): 433–4
- Khojasteh A, Sartiane G, Tapazogfou E, et al. Ondansetron for the prevention of emesis induced by high-dose cisplatin: a multi-center dose-response study. Cancer 1990; 66(6): 1101–5
- Hamsworth J, Harvey W, Pendergrass K, et al. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 1991;9(5): 721–8
- Roila F, Tonato M, Cognetti F, et al. Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991; 9(4): 675–8
- Bonneterre J, Chevallier B, Metz R, et al. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. J Clin Oncol 1990; 8(6): 1063–9
- Carden PA, Mitchell SL, Waters KD, et al. Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia. J Clin Oncol 1990; 8(9): 1531–5
- Einhorn LH, Nagy C, Werner K, et al. Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy. J Clin Oncol 1990; 8(4): 731–5
- Sridhar KS, Donnelly E. Combination antiemetics for cisplatin chemotherapy. Cancer 1988;61(8): 1508–17
- Kris MG, Gralla RJ, Clark RA, et al. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone: a double-blind, randomized trial. Cancer 1987: 60(11): 2816–22
- Kris MG, Gralla RJ, Tyson LB, et al. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine: results of consecutive trials in 255 patients. Cancer 1985; 55(3): 527–34
- Tyson LB, Kris MG, Gralla RJ, et al. Double-blind, randomized trial for the control of delayed emesis: comparison of placebo vs dexamethasone vs metoclopramide plus dexamethasone. Proc Am Soc Clin Oncol 1987; 6:267
- Beck TM. Efficacy of ondansetron tablets in the management of chemotherapy-induced emesis: review of clinical trials. Semin Oncol 1992: 19(15 Suppl): 20–5